Kamada KMDA
NASDAQ KMDA
$7.69 +0.46 (+6.36%)
At close: Nov 9, 2026 · 4:00 PM EST

Kamada (KMDA) Return on Equity [ROE] (2018 - 2026)

Updated

Kamada (KMDA) recorded Return on Equity [ROE] of 8.41% in the quarter ended Jun 30, 2026, up 0.99 percentage points from 7.43% a year earlier and up 0.71 percentage points from the prior quarter.

Analysis

Kamada (KMDA) Return on Equity [ROE] (2018 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Kamada reported Return on Equity [ROE] of 7.64%, up 1.90 percentage points from the prior year.

  • Annual Return on Equity [ROE] has increased for three straight years, though with a five-year change of -3.28 percentage points (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Return on Equity [ROE] came in at 5.74% in the year ended Dec 31, 2024 (+1.80 pp), 3.94% in the year ended Dec 31, 2023 (+5.26 pp), -1.32% in the year ended Dec 31, 2022 (-0.06 pp) and -1.25% in the year ended Dec 31, 2021 (-12.17 pp).
  • The figure for the quarter ended Jun 30, 2026 is the highest quarterly Return on Equity [ROE] since the quarter ended Dec 31, 2020.
  • On a year-over-year basis, Return on Equity [ROE] has increased for 14 consecutive quarters, with an average year-over-year change of +1.75 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 15.19 percentage points in the quarter ended Jun 30, 2023, against a drop of 19.89 percentage points in the quarter ended Jun 30, 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at 7.71% (quarter ended Mar 31, 2026), 7.56% (quarter ended Dec 31, 2025) and 7.79% (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 19.33%
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn -
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 5.63%
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 21.60%
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 72.13%
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -31.17%
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 4.66%
10 Kamada 441.57 Mn 150.63 Mn 22.47 Mn 8.41%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.41%
Mar 31, 2026 7.71%
Dec 31, 2025 7.56%
Sep 30, 2025 7.79%
Jun 30, 2025 7.43%
Mar 31, 2025 6.28%
Dec 31, 2024 5.62%
Sep 30, 2024 6.21%
Jun 30, 2024 6.00%
Mar 31, 2024 5.03%
Dec 31, 2023 3.43%
Sep 30, 2023 2.97%
Jun 30, 2023 1.95%
Mar 31, 2023 -1.31%
Dec 31, 2022 -2.63%
Sep 30, 2022 -5,971.09%
Jun 30, 2022 -13.24%
Mar 31, 2022 -3.83%
Dec 31, 2021 -1.24%
Sep 30, 2021 2.51%
API Access

Kamada Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=KMDA&period=max&api_key=YOUR_API_KEY